Does a combined IV and SC insulin strategy reduce surgical morbidity and mortality in diabetic patients undergoing cardiac surgery?
A combined IV and SC insulin strategy is a less costly and less nursing-intensive alternative that reduces surgical morbidity and mortality in diabetic patients after cardiac surgery.
A combination of IV insulin (in the ICU) and SC insulin (outside the ICU), a less costly and less nursing-intensive therapy than 3 days of IV insulin postoperatively, results in a reduction of the increased surgical morbidity and mortality in diabetic patients after CT surgery.
Schmeltz et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: